This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Can Molson Coors' (TAP) Strategies Outrun Inflation Woes in Q2?
by Zacks Equity Research
Molson Coors' (TAP) strategic investments and premiumization efforts drive robust growth amid industry challenges and inflationary pressures. Let us see how the Q2 performance is likely to have been.
Medifast (MED) Q2 Earnings in the Cards: Factors to Watch
by Zacks Equity Research
Medifast's (MED) Q2 results are likely to reflect customer acquisition challenges stemming from the growth of GLP-1 medications in markets.
Pilgrim's Pride (PPC) Q2 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Pilgrim's Pride's (PPC) second-quarter results reflect earnings and sales growth due to portfolio diversification strategies, operational excellence, branded offerings and key customer partnerships.
US Foods (USFD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
US Foods (USFD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mondelez (MDLZ) Q2 Earnings Beat, Organic Revenues Up 2.5%
by Zacks Equity Research
Mondelez (MDLZ) posts soft sales in second-quarter 2024, whereas organic revenues grow 2.5%. Strong pricing and cost management actions also fuel bottom-line growth.
Is BRF (BRFS) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how BRF (BRFS) and Freshpet (FRPT) have performed compared to their sector so far this year.
Kraft Heinz (KHC) Tops Q2 Earnings Estimates
by Zacks Equity Research
Kraft Heinz (KHC) delivered earnings and revenue surprises of 6.85% and 0.93%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Freshpet (FRPT) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
Freshpet (FRPT) reachead $118.52 at the closing of the latest trading day, reflecting a -1.61% change compared to its last close.
Archer Daniels (ADM) Q2 Earnings & Revenues Miss, Down Y/Y
by Zacks Equity Research
Archer Daniels (ADM) reports lower revenues year over year in second-quarter 2024 owing to a decline in sales across its segments.
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Can Clorox's (CLX) Pricing & Cost-Saving Plan Aid Q4 Earnings?
by Zacks Equity Research
Clorox's (CLX) Q4 results are expected to reflect gains from pricing strategies and cost-saving initiatives, as well as progress on the IGNITE strategy, amid high SG&A expenses.
Freshpet (FRPT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Freshpet (FRPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Take the Zacks Approach to Beat the Markets: Chewy, Pitney Bowes, 3M in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Newell's (NWL) Q2 Earnings Beat Mark, Soft Core Sales Hurt
by Zacks Equity Research
Newell (NWL) reports a sales decline in second-quarter 2024, owing to a core sales drop of 4.2% year over year.
Colgate (CL) Stock Gains on Q2 Earnings Beat, '24 EPS View Hike
by Zacks Equity Research
Colgate's (CL) Q2 results reflect continued gains in volume and pricing, offset by greater negative impacts of currency, leading to robust organic sales growth. CL raises the adjusted EPS view for 2024.
FEMSA (FMX) Posts Sturdy Q2 Growth: Revenues & Earnings Up Y/Y
by Zacks Equity Research
FEMSA (FMX) Q2 results showcase broad-based growth across its business units and an improved operating margin despite adverse weather conditions and strong year-over-year comparisons.
Keurig (KDP) Q2 Earnings Meet Estimates, Volumes Drive Sales
by Zacks Equity Research
Keurig's (KDP) second-quarter 2024 results reflect impressive net sales trends, considerable margin growth and solid earnings improvement.
Lamb Weston (LW) Q4 Earnings & Sales Lag Estimates, Down Y/Y
by Zacks Equity Research
Lamb Weston's (LW) fourth-quarter fiscal 2024 results reflect lower earnings and sales on more-than-anticipated market share losses and a slowdown in restaurant traffic.
Inter Parfums' (IPAR) Q2 Sales Rise on Robust Fragrance Demand
by Zacks Equity Research
Inter Parfums' (IPAR) sales have increased year over year in second-quarter 2024, driven by ongoing momentum in the fragrance market.
Philip Morris (PM) Ups View on Q2 Earnings Beat: Pricing Aids
by Zacks Equity Research
Philip Morris' (PM) second-quarter 2024 results reflect continued strength in pricing and the company's smoke-free business. Management raises guidance despite adverse currency fluctuations.
Service Corporation (SCI) Thrives on Cemetery Unit, Growth Drive
by Zacks Equity Research
Service Corporation (SCI) benefits from strength in its Cemetery segment and a focus on strengthening its network.
Coca-Cola (KO) Advances on Q2 Earnings Beat, Higher Forecast
by Zacks Equity Research
Coca-Cola's (KO) Q2 results highlight the benefits of an enhanced price/mix and rising concentrate sales, driven by regional growth and improved margins boosting profits.
Kimberly-Clark (KMB) Tops Q2 Earnings Estimates, Ups FY24 View
by Zacks Equity Research
Kimberly-Clark's (KMB) second-quarter 2024 results reflect higher earnings on increased operating profit. Taking into account solid first-half results, management raised its annual profit view.
Monster Beverage (MNST) Stock Slides YTD: Is Recovery Likely?
by Zacks Equity Research
Monster Beverage (MNST) looks well-poised for long-term growth, backed by strength in its energy drinks business, continued innovation and product launches.
Philip Morris' (PM) New Investment to Fuel Smoke-Free Growth?
by Zacks Equity Research
Philip Morris' (PM) announcement of a $600 million investment to establish a manufacturing facility in Aurora, CO, presents several strategic advantages and promising growth opportunities.